Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000494957 | SCV000578160 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Ambry Genetics | RCV000569443 | SCV000665116 | likely benign | Hereditary cancer-predisposing syndrome | 2016-10-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000938370 | SCV001133478 | likely benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001437715 | SCV001640576 | likely benign | Hereditary breast ovarian cancer syndrome | 2022-12-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002469174 | SCV002766349 | likely benign | not specified | 2022-11-03 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000569443 | SCV004361073 | likely benign | Hereditary cancer-predisposing syndrome | 2022-03-22 | criteria provided, single submitter | clinical testing |